Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,765
Total Claims
$4.7M
Drug Cost
869
Beneficiaries
$5,447
Cost/Patient
Risk Score Breakdown 22/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-92%
Opioid rate vs peers
0.2% vs 2.6% avg
+410%
Cost per patient vs peers
$5,447 vs $1,068 avg
+129%
Brand preference vs peers
20.6% vs 9.0% avg
Opioid Prescribing
0.2%
Opioid Rate
46
Opioid Claims
$866
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,592 claims · $4.1M
Generic: 17,653 claims · $589K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 316 | $381K |
| Dulaglutide | 236 | $305K |
| Empagliflozin | 272 | $305K |
| Lipase/Protease/Amylase | 109 | $286K |
| Semaglutide | 203 | $276K |
| Lipase/Protease/Amylase | 99 | $251K |
| Semaglutide | 210 | $236K |
| Mirabegron | 197 | $173K |
| Dapagliflozin Propanediol | 173 | $162K |
| Rivaroxaban | 152 | $158K |
| Linaclotide | 152 | $133K |
| Linagliptin | 83 | $108K |
| Insulin Degludec | 113 | $106K |
| Sitagliptin Phosphate | 64 | $94K |
| Insulin Glargine,hum.Rec.Anlog | 140 | $77K |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data